Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2015 (2015), Article ID 183590, 11 pages
http://dx.doi.org/10.1155/2015/183590
Review Article

Tumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell Leukemia

Department of Pathology and Laboratory Medicine, Center for Viral Oncology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA

Received 14 March 2015; Accepted 24 May 2015

Academic Editor: Michiel W. M. van den Brekel

Copyright © 2015 Christophe Nicot. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. J. Poiesz, F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo, “Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 77, no. 12, pp. 7415–7419, 1980. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Yoshida, I. Miyoshi, and Y. Hinuma, “Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no. 6, pp. 2031–2035, 1982. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Yoshida, I. Miyoshi, and Y. Hinuma, “A retrovirus from human leukemia cell lines: its isolation, characterization, and implication in human adult T-cell leukemia (ATL),” Princess Takamatsu Symposia, vol. 12, pp. 285–294, 1982. View at Google Scholar · View at Scopus
  4. A. Gessain and O. Cassar, “Epidemiological aspects and world distribution of HTLV-1 infection,” Frontiers in Microbiology, vol. 3, article 388, Article ID Article 388, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Iwanaga, T. Watanabe, and K. Yamaguchi, “Adultt-cell leukemia: a review of epidemiological evidence,” Frontiers in Microbiology, vol. 3, article 322, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Takatsuki, K. Yamaguchi, F. Kawano et al., “Clinical diversity in adult T-cell leukemia-lymphoma,” Cancer Research, vol. 45, pp. 4644s–4645s, 1985. View at Google Scholar · View at Scopus
  7. K. Tsukasaki, O. Hermine, A. Bazarbachi et al., “Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting,” Journal of Clinical Oncology, vol. 27, no. 3, pp. 453–459, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Wong-Staal, B. Hahn, V. Manzari et al., “A survey of human leukaemias for sequences of a human retrovirus,” Nature, vol. 302, no. 5909, pp. 626–628, 1983. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Yoshida, M. Seiki, K. Yamaguchi, and K. Takatsuki, “Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 81, no. 8, pp. 2534–2537, 1984. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Bazarbachi, F. Suarez, P. Fields, and O. Hermine, “How I treat adult T-cell leukemia/lymphoma,” Blood, vol. 118, no. 7, pp. 1736–1745, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Shimoyama, “Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the lymphoma study group (1984–87),” British Journal of Haematology, vol. 79, no. 3, pp. 428–437, 1991. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Bazarbachi, Y. Plumelle, J. C. Ramos et al., “Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes,” Journal of Clinical Oncology, vol. 28, no. 27, pp. 4177–4183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Kfoury, R. Nasr, C. Journo, R. Mahieux, C. Pique, and A. Bazarbachi, “The multifaceted oncoprotein Tax. subcellular localization, posttranslational modifications, and NF-κB activation,” Advances in Cancer Research, vol. 113, pp. 85–120, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Bellon, H. H. Baydoun, Y. Yao, and C. Nicot, “HTLV-I tax-dependent and -independent events associated with immortalization of human primary T lymphocytes,” Blood, vol. 115, no. 12, pp. 2441–2448, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. N. A. Gillet, N. Malani, A. Melamed et al., “The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones,” Blood, vol. 117, no. 11, pp. 3113–3122, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Miller, T. Mohandas, D. Wolf, M. Prokocimer, V. Rotter, and H. P. Koeffler, “Human p53 gene localized to short arm of chromosome 17,” Nature, vol. 319, no. 6056, pp. 783–784, 1986. View at Publisher · View at Google Scholar · View at Scopus
  17. O. W. McBride, D. Merry, and D. Givol, “The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13),” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 1, pp. 130–134, 1986. View at Google Scholar · View at Scopus
  18. S. J. Baker, E. R. Fearon, J. M. Nigro et al., “Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas,” Science, vol. 244, no. 4901, pp. 217–221, 1989. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Nigro, S. J. Baker, A. C. Preisinger et al., “Mutations in the p53 gene occur in diverse human tumour types,” Nature, vol. 342, no. 6250, pp. 705–708, 1989. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Gaidano, P. Ballerini, J. Z. Gong et al., “p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 12, pp. 5413–5417, 1991. View at Google Scholar · View at Scopus
  21. A. Sakashita, T. Hattori, C. W. Miller et al., “Mutations of the p53 gene in adult T-cell leukemia,” Blood, vol. 79, no. 2, pp. 477–480, 1992. View at Google Scholar · View at Scopus
  22. E. Cesarman, A. Chadburn, G. Inghirami, G. Gaidano, and D. M. Knowles, “Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations,” Blood, vol. 80, no. 12, pp. 3205–3216, 1992. View at Google Scholar · View at Scopus
  23. H. Nagai, T. Kinoshita, J. Imamura et al., “Genetic alteration of p53 in some patients with adult T-cell leukemia,” Japanese Journal of Cancer Research, vol. 82, no. 12, pp. 1421–1427, 1991. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Tawara, S. J. Hogerzeil, Y. Yamada et al., “Impact of p53 aberration on the progression of Adult T-cell leukemia/lymphoma,” Cancer Letters, vol. 234, no. 2, pp. 249–255, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Yamato, T. Oka, M. Hiroi et al., “Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infected cells,” Japanese Journal of Cancer Research, vol. 84, no. 1, pp. 4–8, 1993. View at Publisher · View at Google Scholar · View at Scopus
  26. R. L. Reid, P. F. Lindholm, A. Mireskandari, J. Dittmer, and J. N. Brady, “Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I,” Oncogene, vol. 8, no. 11, pp. 3029–3036, 1993. View at Google Scholar · View at Scopus
  27. S. Takemoto, R. Trovato, A. Cereseto et al., “p53 Stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(APF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells,” Blood, vol. 95, no. 12, pp. 3939–3944, 2000. View at Google Scholar · View at Scopus
  28. T. Akagi, H. Ono, N. Tsuchida, and K. Shimotohno, “Aberrant expression and function of p53 in T cells immortalized by HTLV-I Tax1,” FEBS Letters, vol. 406, no. 3, pp. 263–266, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. C. A. Pise-Masison, K.-S. Choi, M. Radonovich, J. Dittmer, S.-J. Kim, and J. N. Brady, “Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein,” Journal of Virology, vol. 72, no. 2, pp. 1165–1170, 1998. View at Google Scholar · View at Scopus
  30. C. A. Pise-Masison, R. Mahieux, H. Jiang et al., “Inactivation of p53 by human T-cell lymphotropic virus type 1 tax requires activation of the NF-κB pathway and is dependent on p53 phosphorylation,” Molecular and Cellular Biology, vol. 20, no. 10, pp. 3377–3386, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. J. C. Mulloy, T. Kislyakova, A. Cereseto et al., “Human T-cell lymphotropic/leukemia virus type 1 tax abrogates p53- induced cell cycle arrest and apoptosis through its CREB/ATF functional domain,” Journal of Virology, vol. 72, no. 11, pp. 8852–8860, 1998. View at Google Scholar · View at Scopus
  32. C. A. Pise-Masison, R. Mahieux, M. Radonovich, H. Jiang, and J. N. Brady, “Human T-lymphotropic virus type I Tax protein utilizes distinct pathways for p53 inhibition that are cell type-dependent,” The Journal of Biological Chemistry, vol. 276, no. 1, pp. 200–205, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. N. L. Ko, J. M. Taylor, M. Bellon et al., “PA28γ is a novel corepressor of HTLV-1 replication and controls viral latency,” Blood, vol. 121, no. 5, pp. 791–800, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Satou, J. I. Yasunaga, M. Yoshida, and M. Matsuoka, “HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 3, pp. 720–725, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Agirre, F. J. Novo, M. J. Calasanz et al., “TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia,” Molecular Carcinogenesis, vol. 38, no. 4, pp. 201–208, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. D.-T. Wang, Z.-L. Ma, Y.-L. Li et al., “miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis,” Oncology Reports, vol. 30, no. 1, pp. 492–498, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Bellon, Y. Lepelletier, O. Hermine, and C. Nicot, “Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia,” Blood, vol. 113, no. 20, pp. 4914–4917, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. S.-J. Jeong, M. Radonovich, J. N. Brady, and C. A. Pise-Masison, “HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity,” Blood, vol. 104, no. 5, pp. 1490–1497, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Yamagishi, K. Nakano, A. Miyake et al., “Polycomb-mediated loss of miR-31 activates nik-dependent NF-κB pathway in adult T cell leukemia and other cancers,” Cancer Cell, vol. 21, no. 1, pp. 121–135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. K.-J. Jung, A. Dasgupta, K. Huang et al., “Small-molecule inhibitor which reactivates p53 in human T-cell leukemia virus type 1-transformed cells,” Journal of Virology, vol. 82, no. 17, pp. 8537–8547, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Datta, M. Bellon, U. Sinha-Datta et al., “Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence,” Blood, vol. 108, no. 3, pp. 1021–1029, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Ichimiya, Y. Nimura, H. Kageyama et al., “p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent,” Oncogene, vol. 18, no. 4, pp. 1061–1066, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Kaghad, H. Bonnet, A. Yang et al., “Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers,” Cell, vol. 90, no. 4, pp. 809–819, 1997. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Kawano, C. W. Miller, A. Gombart et al., “Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation,” Blood, vol. 94, no. 3, pp. 1113–1120, 1999. View at Google Scholar · View at Scopus
  45. H. Sato, T. Oka, Y. Shinnou et al., “Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma,” The American Journal of Pathology, vol. 176, no. 1, pp. 402–415, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. I. Lemasson and J. K. Nyborg, “Human T-cell leukemia virus type I tax repression of p73β is mediated through competition for the C/H1 domain of CBP,” The Journal of Biological Chemistry, vol. 276, no. 19, pp. 15720–15727, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Kaida, Y. Ariumi, Y. Ueda et al., “Functional impairment of p73 and p51, the p53-related proteins, by the human T-cell leukemia virus type 1 Tax oncoprotein,” Oncogene, vol. 19, no. 6, pp. 827–830, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. R. T. Williams and C. J. Sherr, “The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias,” Cold Spring Harbor Symposia on Quantitative Biology, vol. 73, pp. 461–467, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Caldas, S. A. Hahn, L. T. da Costa et al., “Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma,” Nature Genetics, vol. 8, no. 1, pp. 27–32, 1994. View at Publisher · View at Google Scholar
  50. D. Bartsch, D. W. Shevlin, W. S. Tung, O. Kisker, S. A. Wells Jr., and P. J. Goodfellow, “Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas,” Genes Chromosomes and Cancer, vol. 14, no. 3, pp. 189–195, 1995. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Liu, N. J. Lassam, J. M. Slingerland et al., “Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma,” Oncogene, vol. 11, no. 2, pp. 404–412, 1995. View at Google Scholar · View at Scopus
  52. R. Trovato, A. Cereseto, S. Takemoto et al., “Deletion of the p16INK4A gene in ex vivo acute adult T cell lymphoma/leukemia cells and methylation of the p16INK4A promoter in HTLV type I-infected T cell lines,” AIDS Research and Human Retroviruses, vol. 16, no. 8, pp. 709–713, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Uchida, T. Kinoshita, T. Murate, H. Saito, and T. Hotta, “CDKN2 (MTS1/p16INK4A) gene alterations in adult T-cell leukemia/lymphoma,” Leukemia & Lymphoma, vol. 29, no. 1-2, pp. 27–35, 1998. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Hatta, T. Hirama, C. W. Miller, Y. Yamada, M. Tomonaga, and H. P. Koeffler, “Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia,” Blood, vol. 85, no. 10, pp. 2699–2704, 1995. View at Google Scholar · View at Scopus
  55. K. Uenogawa, Y. Hatta, N. Arima et al., “Azacitidine induces demethylation of p16INK4a and inhibits growth in adult T-cell leukemia/lymphoma,” International Journal of Molecular Medicine, vol. 28, no. 5, pp. 835–839, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. M. S. Pombo-de-Oliveira, J. A. Dobbin, P. Loureiro et al., “Genetic mutation and early onset of T-cell leukemia in pediatric patients infected at birth with HTLV-I,” Leukemia Research, vol. 26, no. 2, pp. 155–161, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. M. J. Bueno and M. Malumbres, “MicroRNAs and the cell cycle,” Biochimica et Biophysica Acta, vol. 1812, no. 5, pp. 592–601, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. M. J. Bueno, I. P. de Castro, and M. Malumbres, “Control of cell proliferation pathways by microRNAs,” Cell Cycle, vol. 7, no. 20, pp. 3143–3148, 2008. View at Google Scholar · View at Scopus
  59. M. Yamagishi, K. Nakano, A. Miyake et al., “Polycomb-mediated loss of miR-31 activates nik-dependent NF-κB pathway in adult T cell leukemia and other cancers,” Cancer Cell, vol. 21, no. 1, pp. 121–135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Suzuki, T. Narita, M. Uchida-Toita, and M. Yoshida, “Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms,” Virology, vol. 259, no. 2, pp. 384–391, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. T. Suzuki, S. Kitao, H. Matsushime, and M. Yoshida, “HTLV-1 tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4,” The EMBO Journal, vol. 15, no. 7, pp. 1607–1614, 1996. View at Google Scholar · View at Scopus
  62. D. Bertwistle, M. Sugimoto, and C. J. Sherr, “Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23,” Molecular and Cellular Biology, vol. 24, no. 3, pp. 985–996, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Rizos, A. P. Darmanian, E. A. Holland, G. J. Mann, and R. F. Kefford, “Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF,” The Journal of Biological Chemistry, vol. 276, no. 44, pp. 41424–41434, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. N. Burri, P. Shaw, H. Bouzourene et al., “Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer,” Laboratory Investigation, vol. 81, no. 2, pp. 217–229, 2001. View at Publisher · View at Google Scholar · View at Scopus
  65. D. K. Bartsch, M. Sina-Frey, S. Lang et al., “CDKN2A germline mutations in familial pancreatic cancer,” Annals of Surgery, vol. 236, no. 6, pp. 730–737, 2002. View at Publisher · View at Google Scholar · View at Scopus
  66. S. W. Blain, E. Montalvo, and J. Massagué, “Differential interaction of the cyclin-dependent kinase (CDK) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4,” The Journal of Biological Chemistry, vol. 272, no. 41, pp. 25863–25872, 1997. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Labaer, M. D. Garrett, L. F. Stevenson et al., “New functional activities for the p21 family of CDK inhibitors,” Genes and Development, vol. 11, no. 7, pp. 847–862, 1997. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Hashimoto, K. Kohri, Y. Kaneko et al., “Critical role for the 310 helix region of p57Kip2 in cyclin-dependent kinase 2 inhibition and growth suppression,” The Journal of Biological Chemistry, vol. 273, no. 26, pp. 16544–16550, 1998. View at Publisher · View at Google Scholar
  69. W. S. El-Deiry, T. Tokino, V. E. Velculescu et al., “WAF1, a potential mediator of p53 tumor suppression,” Cell, vol. 75, no. 4, pp. 817–825, 1993. View at Google Scholar · View at Scopus
  70. A. L. Gartel and S. K. Radhakrishnan, “Lost in transcription: p21 repression, mechanisms, and consequences,” Cancer Research, vol. 65, no. 10, pp. 3980–3985, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. C. de la Fuente, F. Santiago, L. Deng et al., “Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A/cdk2,” Journal of Virology, vol. 74, no. 16, pp. 7270–7283, 2000. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Watanabe, S. Nakahata, M. Hamasaki et al., “Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines,” Journal of Virology, vol. 84, no. 14, pp. 6966–6977, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. Y.-K. Kim, J. Yu, T. S. Han et al., “Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer,” Nucleic Acids Research, vol. 37, no. 5, pp. 1672–1681, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. G. C. Sampey, R. Van Duyne, R. Currer, R. Das, A. Narayanan, and F. Kashanchi, “Complex role of microRNAs in HTLV-1 infections,” Frontiers in Genetics, vol. 3, article 295, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. A. Cereseto, R. W. Parks, E. Rivadeneira, and G. Franchini, “Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T cells,” Oncogene, vol. 18, no. 15, pp. 2441–2450, 1999. View at Publisher · View at Google Scholar · View at Scopus
  76. R. Morosetti, N. Kawamata, A. F. Gombart et al., “Alterations of the p27KIP1 Gene in Non-Hodgkin's Lymphomas and Adult T-Cell Leukemia/Lymphoma,” Blood, vol. 86, no. 5, pp. 1924–1930, 1995. View at Google Scholar · View at Scopus
  77. W. Roeb, A. Boyer, W. K. Cavenee, and K. C. Arden, “PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 46, pp. 18085–18090, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Matsuoka, M. C. Edwards, C. Bai et al., “P57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene,” Genes and Development, vol. 9, no. 6, pp. 650–662, 1995. View at Publisher · View at Google Scholar · View at Scopus
  79. I. Hatada, A. Nabetani, H. Morisaki et al., “New p57KIP2 mutations in Beckwith-Wiedemann syndrome,” Human Genetics, vol. 100, no. 5-6, pp. 681–683, 1997. View at Publisher · View at Google Scholar · View at Scopus
  80. I. S. Pateras, K. Apostolopoulou, K. Niforou, A. Kotsinas, and V. G. Gorgoulis, “p57KIP2: ‘kip’ing the cell under control,” Molecular Cancer Research, vol. 7, no. 12, pp. 1902–1919, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. X. Yang, R. K. M. Karuturi, F. Sun et al., “CDKN1C (p57KIP2) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells,” PLoS ONE, vol. 4, Article ID e5011, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. L. Shen, M. Toyota, Y. Kondo et al., “Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia,” Blood, vol. 101, no. 10, pp. 4131–4136, 2003. View at Publisher · View at Google Scholar · View at Scopus
  83. F. Fornari, L. Gramantieri, M. Ferracin et al., “MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma,” Oncogene, vol. 27, no. 43, pp. 5651–5661, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. R. Medina, S. K. Zaidi, C.-G. Liu et al., “MicroRNAs 221 and 222 bypass quiescence and compromise cell survival,” Cancer Research, vol. 68, no. 8, pp. 2773–2780, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Sengupta, J. Nie, R. J. Wagner, C. Yang, R. Stewart, and J. A. Thomson, “MicroRNA 92b controls the G1/S checkpoint gene p57 in human embryonic stem cells,” Stem Cells, vol. 27, no. 7, pp. 1524–1528, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. D. G. Johnson and R. Schneider-Broussard, “Role of E2F in cell cycle control and cancer,” Frontiers in Bioscience, vol. 3, pp. d447–d448, 1998. View at Google Scholar · View at Scopus
  87. S. A. Henley and F. A. Dick, “The retinoblastoma family of proteins and their regulatory functions in the mammalian cell division cycle,” Cell Division, vol. 7, article 10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. P. Indovina, E. Marcelli, N. Casini, V. Rizzo, and A. Giordano, “Emerging roles of RB family: new defense mechanisms against tumor progression,” Journal of Cellular Physiology, vol. 228, no. 3, pp. 525–535, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. Y. Hatta, Y. Yamada, M. Tomonaga, and H. P. Koeffler, “Extensive analysis of the retinoblastoma gene in adult T cell leukemia/lymphoma (ATL),” Leukemia, vol. 11, no. 7, pp. 984–989, 1997. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Takeuchi, N. Takeuchi, K. Tsukasaki et al., “Mutations in the retinoblastoma-related gene RB2/p130 in adult T-cell leukaemia/lymphoma,” Leukemia and Lymphoma, vol. 44, no. 4, pp. 699–701, 2003. View at Publisher · View at Google Scholar · View at Scopus
  91. A. Hangaishi, S. Ogawa, N. Imamura et al., “Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies,” Blood, vol. 87, no. 12, pp. 4949–4958, 1996. View at Google Scholar · View at Scopus
  92. K. Nakayama, Y. Yamada, T. Koji, T. Hayashi, M. Tomonaga, and S. Kamihira, “Expression and phosphorylation status of retinoblastoma protein in adult T-cell leukemia/lymphoma,” Leukemia Research, vol. 24, no. 4, pp. 299–305, 2000. View at Publisher · View at Google Scholar · View at Scopus
  93. D. Jiang and R. C. T. Aguiar, “MicroRNA-155 controls RB phosphorylation in normal and malignant B lymphocytes via the noncanonical TGF-β1/SMAD5 signaling module,” Blood, vol. 123, no. 1, pp. 86–93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  94. K. Kehn, C. de la Fuente, K. Strouss et al., “The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation,” Oncogene, vol. 24, no. 4, pp. 525–540, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. P. A. Steck, M. A. Pershouse, S. A. Jasser et al., “Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers,” Nature Genetics, vol. 15, no. 4, pp. 356–362, 1997. View at Publisher · View at Google Scholar · View at Scopus
  96. Y. Yin and W. H. Shen, “PTEN: a new guardian of the genome,” Oncogene, vol. 27, no. 41, pp. 5443–5453, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. E. C. Chu and A. S. Tarnawski, “PTEN regulatory functions in tumor suppression and cell biology,” Medical Science Monitor, vol. 10, no. 10, pp. RA235–RA241, 2004. View at Google Scholar · View at Scopus
  98. M. C. Hollander, G. M. Blumenthal, and P. A. Dennis, “PTEN loss in the continuum of common cancers, rare syndromes and mouse models,” Nature Reviews Cancer, vol. 11, no. 4, pp. 289–301, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. J. Pancewicza, J. M. Taylora, A. Dattaa et al., “Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 38, pp. 16619–16624, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. J. E. Damen, L. Liu, P. Rosten et al., “The 145-kDa protein induced to associate with She by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 4, pp. 1689–1693, 1996. View at Google Scholar · View at Scopus
  101. G. Krystal, J. E. Damen, C. D. Helgason et al., “SHIPs ahoy,” International Journal of Biochemistry and Cell Biology, vol. 31, no. 10, pp. 1007–1010, 1999. View at Publisher · View at Google Scholar · View at Scopus
  102. K. Nakase, J. Cheng, Q. Zhu, and W. A. Marasco, “Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells,” Journal of Leukocyte Biology, vol. 85, no. 1, pp. 165–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. Q. Zhang, P. N. Raghunath, E. Vonderheid, N. Odum, and M. A. Wasik, “Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter,” American Journal of Pathology, vol. 157, no. 4, pp. 1137–1146, 2000. View at Publisher · View at Google Scholar · View at Scopus
  104. J. Cheng, D. Zhang, C. Zhou, and W. A. Marasco, “Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T cells,” Leukemia Research, vol. 28, no. 1, pp. 71–82, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. T.-S. Migone, N. A. Cacalano, N. Taylor, T. Yi, T. A. Waldmann, and J. A. Johnston, “Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 7, pp. 3845–3850, 1998. View at Publisher · View at Google Scholar · View at Scopus
  106. M. Garofalo, G. Di Leva, G. Romano et al., “miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation,” Cancer Cell, vol. 16, no. 6, pp. 498–509, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. Y.-N. Bai, Z.-Y. Yu, L.-X. Luo, J. Yi, Q.-J. Xia, and Y. Zeng, “MicroRNA-21 accelerates hepatocyte proliferation in vitro via PI3K/Akt signaling by targeting PTEN,” Biochemical and Biophysical Research Communications, vol. 443, no. 3, pp. 802–807, 2014. View at Publisher · View at Google Scholar · View at Scopus
  108. R. M. O'Connell, A. A. Chaudhuri, D. S. Rao, and D. Baltimore, “Inositol phosphatase SHIP1 is a primary target of miR-155,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 17, pp. 7113–7118, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. G. M. Caldwell, C. Jones, K. Gensberg et al., “The Wnt antagonist sFRP1 in colorectal tumorigenesis,” Cancer Research, vol. 64, no. 3, pp. 883–888, 2004. View at Publisher · View at Google Scholar · View at Scopus
  110. R. Stoehr, C. Wissmann, H. Suzuki et al., “Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer,” Laboratory Investigation, vol. 84, no. 4, pp. 465–478, 2004. View at Publisher · View at Google Scholar · View at Scopus
  111. M. L. Gumz, H. Zou, P. A. Kreinest et al., “Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma,” Clinical Cancer Research, vol. 13, no. 16, pp. 4740–4749, 2007. View at Publisher · View at Google Scholar · View at Scopus
  112. T. Fukui, M. Kondo, G. Ito et al., “Transcriptional silencing of secreted frizzled related protein 1 (SFRP1) by promoter hypermethylation in non-small-cell lung cancer,” Oncogene, vol. 24, no. 41, pp. 6323–6327, 2005. View at Publisher · View at Google Scholar · View at Scopus
  113. E. Dahl, J. Veeck, H. An et al., “Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer,” Verhandlungen der Deutschen Gesellschaft für Pathologie, vol. 89, pp. 169–177, 2005. View at Google Scholar · View at Scopus
  114. U. Sinha-Datta, I. Horikawa, E. Michishita et al., “Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells,” Blood, vol. 104, no. 8, pp. 2523–2531, 2004. View at Publisher · View at Google Scholar · View at Scopus
  115. N. Uchida, T. Otsuka, F. Arima et al., “Correlation of telomerase activity with development and progression of adult T-cell leukemia,” Leukemia Research, vol. 23, no. 3, pp. 311–316, 1999. View at Publisher · View at Google Scholar · View at Scopus
  116. Y. Kubuki, M. Suzuki, H. Sasaki et al., “Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia,” Leukemia and Lymphoma, vol. 46, no. 3, pp. 393–399, 2005. View at Publisher · View at Google Scholar · View at Scopus
  117. C. Nicot, R. Mahieux, S. Takemoto, and G. Franchini, “Bcl-X(L) is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples,” Blood, vol. 96, no. 1, pp. 275–281, 2000. View at Google Scholar · View at Scopus
  118. Y. B. Choi, E. W. Harhaj, and S. R. Ross, “HTLV-1 tax stabilizes MCL-1 via TRAF6-dependent K63-linked polyubiquitination to promote cell survival and transformation,” PLoS Pathogens, vol. 10, no. 10, 2014. View at Publisher · View at Google Scholar
  119. A. Kawakami, T. Nakashima, H. Sakai et al., “Inhibition of caspase cascade by HTLV-I tax through induction of NF-κB nuclear translocation,” Blood, vol. 94, no. 11, pp. 3847–3854, 1999. View at Google Scholar · View at Scopus
  120. H. Macaire, A. Riquet, V. Moncollin et al., “Tax protein-induced expression of antiapoptotic Bfl-1 protein contributes to survival of human T-cell leukemia virus type 1 (HTLV-1)-infected T cells,” The Journal of Biological Chemistry, vol. 287, no. 25, pp. 21357–21370, 2012. View at Publisher · View at Google Scholar
  121. A. Formosa, A. M. Lena, E. K. Markert et al., “DNA methylation silences miR-132 in prostate cancer,” Oncogene, vol. 32, no. 1, pp. 127–134, 2013. View at Publisher · View at Google Scholar · View at Scopus
  122. M. L. Ufkin, S. Peterson, X. Yang, H. Driscoll, C. Duarte, and P. Sathyanarayana, “miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia,” Leukemia Research, vol. 38, no. 3, pp. 402–410, 2014. View at Publisher · View at Google Scholar · View at Scopus
  123. T. Itoyama, R. S. K. Chaganti, Y. Yamada et al., “Cytogenetic analysis and clinical significance in adult T-cell leukemia/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki,” Blood, vol. 97, no. 11, pp. 3612–3620, 2001. View at Publisher · View at Google Scholar · View at Scopus
  124. N. Kamada, M. Sakurai, K. Miyamoto et al., “Chromosome abnormalities in adult T-cell leukemia/lymphoma: a Karyotype Review Committee report,” Cancer Research, vol. 52, no. 6, pp. 1481–1493, 1992. View at Google Scholar · View at Scopus
  125. T. Dayaram, F. J. Lemoine, L. A. Donehower, and S. J. Marriott, “Activation of WIP1 phosphatase by HTLV-1 Tax mitigates the cellular response to DNA damage,” PLoS ONE, vol. 8, no. 2, Article ID e55989, 2013. View at Publisher · View at Google Scholar · View at Scopus
  126. C. Chandhasin, R. I. Ducu, E. Berkovich, M. B. Kastan, and S. J. Marriott, “Human T-cell leukemia virus type 1 tax attenuates the ATM-mediated cellular DNA damage response,” Journal of Virology, vol. 82, no. 14, pp. 6952–6961, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. H. U. Park, S.-J. Jeong, J.-H. Jeong, J. H. Chung, and J. N. Brady, “Human T-cell leukemia virus type 1 Tax attenuates γ-irradiation- induced apoptosis through physical interaction with Chk2,” Oncogene, vol. 25, no. 3, pp. 438–447, 2006. View at Publisher · View at Google Scholar · View at Scopus
  128. B. Liu, M.-H. Liang, Y.-L. Kuo et al., “Human T-lymphotropic virus type 1 oncoprotein tax promotes unscheduled degradation of Pds1p/securin and Clb2p/cyclin B1 and causes chromosomal instability,” Molecular and Cellular Biology, vol. 23, no. 15, pp. 5269–5281, 2003. View at Publisher · View at Google Scholar · View at Scopus
  129. T. Nitta, M. Kanai, E. Sugihara et al., “Centrosome amplification in adult T-cell leukemia and human T-cell leukemia virus type 1 Tax-induced human T cells,” Cancer Science, vol. 97, no. 9, pp. 836–841, 2006. View at Publisher · View at Google Scholar · View at Scopus
  130. H. Chaib-Mezrag, D. Lemaçon, H. Fontaine et al., “Tax impairs DNA replication forks and increases DNA breaks in specific oncogenic genome regions,” Molecular Cancer, vol. 13, article 205, 2014. View at Publisher · View at Google Scholar
  131. H. H. Baydoun, X. T. Bai, S. Shelton, and C. Nicot, “HTLV-I tax increases genetic instability by inducing DNA double strand breaks during DNA replication and switching repair to NHEJ,” PLoS ONE, vol. 7, no. 8, Article ID e42226, 2012. View at Publisher · View at Google Scholar · View at Scopus
  132. J. German, “Bloom's syndrome. I. Genetical and clinical observations in the first twenty-seven patients.,” The American Journal of Human Genetics, vol. 21, no. 2, pp. 196–227, 1969. View at Google Scholar · View at Scopus
  133. Y. Hatta, Y. Yamada, M. Tomonaga, I. Miyoshi, J. W. Said, and H. P. Koeffler, “Microsatellite instability in adult T-cell leukaemia,” British Journal of Haematology, vol. 101, no. 2, pp. 341–344, 1998. View at Publisher · View at Google Scholar · View at Scopus
  134. Y. Hayami, H. Komatsu, S. Iida et al., “Microsatellite instability as a potential marker for poor prognosis in adult T cell leukemia/lymphoma,” Leukemia and Lymphoma, vol. 32, no. 3-4, pp. 345–349, 1999. View at Google Scholar · View at Scopus
  135. Y. Hatta, M. Wada, S. Takeuchi et al., “Mutational analysis of the hMSH2 gene in a wide variety of tumors,” International Journal of Oncology, vol. 11, no. 3, pp. 465–469, 1997. View at Google Scholar · View at Scopus
  136. H. Morimoto, J. Tsukada, Y. Kominato, and Y. Tanaka, “Reduced expression of human mismatch repair genes in adult T-cell leukemia,” The American Journal of Hematology, vol. 78, no. 2, pp. 100–107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  137. F. J. Lemoine, S.-Y. Kao, and S. J. Marriott, “Suppression of DNA repair by HTLV type 1 Tax correlates with Tax trans-activation of proliferating cell nuclear antigen gene expression,” AIDS Research and Human Retroviruses, vol. 16, no. 16, pp. 1623–1627, 2000. View at Publisher · View at Google Scholar · View at Scopus
  138. S.-Y. Kao and S. J. Marriott, “Disruption of nucleotide excision repair by the human T-cell leukemia virus type 1 Tax protein,” Journal of Virology, vol. 73, no. 5, pp. 4299–4304, 1999. View at Google Scholar · View at Scopus
  139. S. M. Philpott and G. C. Buehring, “Defective DNA repair in cells with human T-cell leukemia/bovine leukemia viruses: role of tax gene,” Journal of the National Cancer Institute, vol. 91, no. 11, pp. 933–942, 1999. View at Google Scholar · View at Scopus
  140. M. Boxus, J.-C. Twizere, S. Legros, R. Kettmann, and L. Willems, “Interaction of HTLV-1 Tax with minichromosome maintenance proteins accelerates the replication timing program,” Blood, vol. 119, no. 1, pp. 151–160, 2012. View at Publisher · View at Google Scholar · View at Scopus
  141. H. Sasaki, I. Nishikata, T. Shiraga et al., “Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia,” Blood, vol. 105, no. 3, pp. 1204–1213, 2005. View at Publisher · View at Google Scholar · View at Scopus
  142. M. Z. Dewan, N. Takamatsu, T. Hidaka et al., “Critical role for TSLC1 expression in the growth and organ infiltration of adult T-cell leukemia cells in vivo,” Journal of Virology, vol. 82, no. 23, pp. 11958–11963, 2008. View at Publisher · View at Google Scholar · View at Scopus
  143. N. Mori, H. Sato, T. Hayashibara et al., “Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness,” Blood, vol. 99, no. 4, pp. 1341–1349, 2002. View at Publisher · View at Google Scholar · View at Scopus
  144. K. Nabeshima, J. Suzumiya, M. Nagano et al., “Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas,” The Journal of Pathology, vol. 202, no. 3, pp. 341–351, 2004. View at Publisher · View at Google Scholar · View at Scopus
  145. M. Masuda, T. Maruyama, T. Ohta et al., “CADM1 interacts with Tiam1 and promotes invasive phenotype of human T-cell leukemia virus type I-transformed cells and adult T-cell leukemia cells,” The Journal of Biological Chemistry, vol. 285, no. 20, pp. 15511–15522, 2010. View at Publisher · View at Google Scholar · View at Scopus